Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 08 2021
Historique:
received: 05 10 2020
accepted: 06 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 24 8 2021
Statut: epublish

Résumé

Human induced pluripotent stem cells (iPSC) hold promise for modeling diseases in individual human genetic backgrounds and thus for developing precision medicine. Here, we generate sensorimotor organoids containing physiologically functional neuromuscular junctions (NMJs) and apply the model to different subgroups of amyotrophic lateral sclerosis (ALS). Using a range of molecular, genomic, and physiological techniques, we identify and characterize motor neurons and skeletal muscle, along with sensory neurons, astrocytes, microglia, and vasculature. Organoid cultures derived from multiple human iPSC lines generated from individuals with ALS and isogenic lines edited to harbor familial ALS mutations show impairment at the level of the NMJ, as detected by both contraction and immunocytochemical measurements. The physiological resolution of the human NMJ synapse, combined with the generation of major cellular cohorts exerting autonomous and non-cell autonomous effects in motor and sensory diseases, may prove valuable to understand the pathophysiological mechanisms of ALS.

Identifiants

pubmed: 34362895
doi: 10.1038/s41467-021-24776-4
pii: 10.1038/s41467-021-24776-4
pmc: PMC8346474
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4744

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK043351
Pays : United States
Organisme : NINDS NIH HHS
ID : DP2 NS106664
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK057521
Pays : United States
Organisme : NINDS NIH HHS
ID : K08 NS082364
Pays : United States
Organisme : NINDS NIH HHS
ID : F32 NS114319
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Fischer, L. R. et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232–240 (2004).
pubmed: 14736504 doi: 10.1016/j.expneurol.2003.10.004
Taylor, J. P., Brown, R. H. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197–206 (2016).
pubmed: 27830784 pmcid: 5585017 doi: 10.1038/nature20413
Klim, J. R. et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167–179 (2019).
pubmed: 30643292 pmcid: 7153761 doi: 10.1038/s41593-018-0300-4
Melamed, Z. et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180–190.
Pasinelli, P. & Brown, R. H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710–723 (2006).
pubmed: 16924260 doi: 10.1038/nrn1971
Dimos, J. T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (80-.) 321, 1218–1221 (2008).
doi: 10.1126/science.1158799
Xu, C. et al. A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species. Cell 155, 909–921 (2013).
pubmed: 24209627 pmcid: 3902670 doi: 10.1016/j.cell.2013.10.023
Osaki, T., Uzel, S. G. M. & Kamm, R. D. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci. Adv. 4, eaat5847 (2018).
pubmed: 30324134 pmcid: 6179377 doi: 10.1126/sciadv.aat5847
Son, E. Y. et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 9, 205–218 (2011).
pubmed: 21852222 pmcid: 3188987 doi: 10.1016/j.stem.2011.07.014
Steinbeck, J. A. et al. Functional connectivity under optogenetic control allows modeling of human neuromuscular disease. Cell Stem Cell 18, 134–143 (2016).
pubmed: 26549107 doi: 10.1016/j.stem.2015.10.002
Santhanam, N. et al. Stem cell derived phenotypic human neuromuscular junction model for dose response evaluation of therapeutics. Biomaterials 166, 64–78 (2018).
pubmed: 29547745 pmcid: 5866791 doi: 10.1016/j.biomaterials.2018.02.047
Lin, C. Y. et al. IPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases. JCI Insight (2019) https://doi.org/10.1172/jci.insight.124299 .
Faustino Martins, J. M. et al. Self-organizing 3D human trunk neuromuscular organoids. Cell Stem Cell (2020) https://doi.org/10.1016/j.stem.2019.12.007 .
Andersen, J. et al. Generation of functional human 3D cortico-motor assembloids. Cell 183, 1913–1929.e26 (2020).
pubmed: 33333020 doi: 10.1016/j.cell.2020.11.017 pmcid: 8711252
Gouti, M. et al. In vitro generation of neuromesodermal progenitors reveals distinct roles for wnt signalling in the specification of spinal cord and paraxial mesoderm identity. PLoS Biol. 12, e1001937 (2014).
pubmed: 25157815 pmcid: 4144800 doi: 10.1371/journal.pbio.1001937
Klein, A. M. et al. Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 161, 1187–1201 (2015).
pubmed: 26000487 pmcid: 4441768 doi: 10.1016/j.cell.2015.04.044
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744 doi: 10.1038/nbt.4096
Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS: J. Integr. Biol. 16, 284–287 (2012).
doi: 10.1089/omi.2011.0118
Meulemans, D. & Bronner-Fraser, M. Gene-regulatory interactions in neural crest evolution and development. Dev. Cell 7, 291–299 (2004).
pubmed: 15363405 doi: 10.1016/j.devcel.2004.08.007
Simões-Costa, M. & Bronner, M. E. Establishing neural crest identity: a gene regulatory recipe. Development 142, 242–257 (2015).
pubmed: 25564621 pmcid: 4302844 doi: 10.1242/dev.105445
Soldatov, R. et al. Spatiotemporal structure of cell fate decisions in murine neural crest. Science (80-.). 364 (2019).
Shimojo, H., Ohtsuka, T. & Kageyama, R. Oscillations in notch signaling regulate maintenance of neural progenitors. Neuron 58, 52–64 (2008).
pubmed: 18400163 doi: 10.1016/j.neuron.2008.02.014
Müller, T. et al. The bHLH factor Olig3 coordinates the specification of dorsal neurons in the spinal cord. Genes Dev. 19, 733–743 (2005).
pubmed: 15769945 pmcid: 1065726 doi: 10.1101/gad.326105
Graham, V., Khudyakov, J., Ellis, P. & Pevny, L. SOX2 functions to maintain neural progenitor identity. Neuron 39, 749–765 (2003).
pubmed: 12948443 doi: 10.1016/S0896-6273(03)00497-5
Tortosa, E. et al. Microtubule-associated protein 1B (MAP1B) is required for dendritic spine development and synaptic maturation. J. Biol. Chem. 286, 40638–40648 (2011).
pubmed: 21984824 pmcid: 3220481 doi: 10.1074/jbc.M111.271320
Kulkeaw, K. et al. Twist1 regulates embryonic hematopoietic differentiation through binding to Myb and Gata2 promoter regions. Blood Adv. 1, 1672–1681 (2017).
pubmed: 29296814 pmcid: 5728333 doi: 10.1182/bloodadvances.2017006056
Ivanovs, A. et al. Human haematopoietic stem cell development: from the embryo to the dish. Development 144, 2323–2337 (2017).
pubmed: 28676567 doi: 10.1242/dev.134866
Greenbaum, A. et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 495, 227–230 (2013).
pubmed: 23434756 pmcid: 3600148 doi: 10.1038/nature11926
Weinreb, C., Wolock, S. & Klein, A. M. SPRING: a kinetic interface for visualizing high dimensional single-cell expression data. Bioinformatics 34, 1246–1248 (2018).
pubmed: 29228172 doi: 10.1093/bioinformatics/btx792
Busskamp, V. et al. Rapid neurogenesis through transcriptional activation in human stem cells. Mol. Syst. Biol. 10, 760–760 (2014).
pubmed: 25403753 pmcid: 4299601 doi: 10.15252/msb.20145508
Ma, Q., Fode, C., Guillemot, F. & Anderson, D. J. Neurogenin1 and neurogenin2 control two distinct waves of neurogenesis in developing dorsal root ganglia. Genes Dev. 13, 1717–1728 (1999).
pubmed: 10398684 pmcid: 316844 doi: 10.1101/gad.13.13.1717
Ma, Y. C. et al. Regulation of motor neuron specification by phosphorylation of neurogenin 2. Neuron 58, 65–77 (2008).
pubmed: 18400164 pmcid: 2587148 doi: 10.1016/j.neuron.2008.01.037
Uemura, O. et al. Comparative functional genomics revealed conservation and diversification of three enhancers of the isl1 gene for motor and sensory neuron-specific expression. Dev. Biol. 278, 587–606 (2005).
pubmed: 15680372 doi: 10.1016/j.ydbio.2004.11.031
Lei, L., Zhou, J., Lin, L. & Parada, L. F. Brn3a and Klf7 cooperate to control TrkA expression in sensory neurons. Dev. Biol. 300, 758–769 (2006).
pubmed: 17011544 doi: 10.1016/j.ydbio.2006.08.062
Fornaro, M. et al. Neuronal intermediate filament expression in rat dorsal root ganglia sensory neurons: An in vivo and in vitro study. Neuroscience 153, 1153–1163 (2008).
pubmed: 18434031 doi: 10.1016/j.neuroscience.2008.02.080
Covault, J. & Sanes, J. R. Neural cell adhesion molecule (N-CAM) accumulates in denervated and paralyzed skeletal muscles. Proc. Natl Acad. Sci. USA 82, 4544–4548 (1985).
pubmed: 3892537 pmcid: 391139 doi: 10.1073/pnas.82.13.4544
Sances, S. et al. Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat. Neurosci. 19, 542–553 (2016).
pubmed: 27021939 pmcid: 5015775 doi: 10.1038/nn.4273
Basbaum, A. I., Bautista, D. M., Scherrer, G. & Julius, D. Cellular and molecular mechanisms of pain. Cell 139, 267–284 (2009).
pubmed: 19837031 pmcid: 2852643 doi: 10.1016/j.cell.2009.09.028
Caterina, M. J. et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389, 816–824 (1997).
pubmed: 9349813 doi: 10.1038/39807
Akopian, A. N., Sivilotti, L. & Wood, J. N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379, 257–262 (1996).
pubmed: 8538791 doi: 10.1038/379257a0
Waxman, S. G. & Zamponi, G. W. Regulating excitability of peripheral afferents: emerging ion channel targets. Nat. Neurosci. 17, 153–163 (2014).
pubmed: 24473263 doi: 10.1038/nn.3602
Sloan, S. A. et al. Human astrocyte maturation captured in 3d cerebral cortical spheroids derived from pluripotent stem cells. Neuron 95, 779–790.e6 (2017).
pubmed: 28817799 pmcid: 5890820 doi: 10.1016/j.neuron.2017.07.035
Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010).
pubmed: 20966214 pmcid: 3719181 doi: 10.1126/science.1194637
Salter, M. W. & Stevens, B. Microglia emerge as central players in brain disease. Nat. Med. 23, 1018–1027 (2017).
pubmed: 28886007 doi: 10.1038/nm.4397
Satoh, J. et al. TMEM119 marks a subset of microglia in the human brain. Neuropathology 36, 39–49 (2016).
pubmed: 26250788 doi: 10.1111/neup.12235
Paolicelli, R. C., Bisht, K. & Tremblay, M.-Ã. Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front. Cell. Neurosci. 8, 129 (2014).
pubmed: 24860431 pmcid: 4026677 doi: 10.3389/fncel.2014.00129
Robertson, R. T. et al. Use of labeled tomato lectin for imaging vasculature structures. Histochem. Cell Biol. 143, 225–234 (2015).
pubmed: 25534591 doi: 10.1007/s00418-014-1301-3
Hall, Z. W. & Sanes, J. R. Synaptic structure and development: the neuromuscular junction. Cell 72, 99–121 (1993).
pubmed: 8428377 doi: 10.1016/S0092-8674(05)80031-5
Hanson, J. & Huxley, H. E. Structural basis of the cross-striations in muscle. Nature 172, 530–532 (1953).
pubmed: 13099257 doi: 10.1038/172530b0
Kummer, T. T., Misgeld, T. & Sanes, J. R. Assembly of the postsynaptic membrane at the neuromuscular junction: paradigm lost. Curr. Opin. Neurobiol. 16, 74–82 (2006).
pubmed: 16386415 doi: 10.1016/j.conb.2005.12.003
Jones, R. A. et al. Cellular and molecular anatomy of the human neuromuscular junction. Cell Rep. 21, 2348–2356 (2017).
pubmed: 29186674 pmcid: 5723673 doi: 10.1016/j.celrep.2017.11.008
Moakley, D. et al. Pharmacological profiling of purified human stem cell-derived and primary mouse motor neurons. Sci. Rep. 9, 10835 (2019).
pubmed: 31346219 pmcid: 6658502 doi: 10.1038/s41598-019-47203-7
Jaramillo, F., Vicini, S. & Schuetze, S. M. Embryonic acetylcholine receptors guarantee spontaneous contractions in rat developing muscle. Nature 335, 66–68 (1988).
pubmed: 3412460 doi: 10.1038/335066a0
Abdelfattah, A. S. et al. A bright and fast red fluorescent protein voltage indicator that reports neuronal activity in organotypic brain slices. J. Neurosci. 36, 2458–2472 (2016).
pubmed: 26911693 pmcid: 4764664 doi: 10.1523/JNEUROSCI.3484-15.2016
Hunter, J. M. New Neuromuscular blocking. Drugs N. Engl. J. Med. 332, 1691–1699 (1995).
pubmed: 7760871 doi: 10.1056/NEJM199506223322507
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772 doi: 10.1038/nmeth.2019
Oates, J. A., Wood, A. J. J., Jankovic, J. & Brin, M. F. Therapeutic uses of botulinum toxin. N. Engl. J. Med. 324, 1186–1194 (1991).
doi: 10.1056/NEJM199104253241707
Pliatsika, V. & Rigoutsos, I. “Off-Spotter”: very fast and exhaustive enumeration of genomic lookalikes for designing CRISPR/Cas guide RNAs. Biol. Direct 10, 4 (2015).
pubmed: 25630343 pmcid: 4326336 doi: 10.1186/s13062-015-0035-z
Koga, T., Bellier, J. P., Kimura, H. & Tooyama, I. Immunoreactivity for choline acetyltransferase of peripheral-type (pChAT) in the trigeminal ganglion neurons of the non-human primate Macaca fascicularis. Acta Histochem. Cytochem. 46, 59–64 (2013).
pubmed: 23720604 pmcid: 3661780 doi: 10.1267/ahc.12044
Quadrato, G. et al. Cell diversity and network dynamics in photosensitive human brain organoids. Nature 545, 48–53 (2017).
pubmed: 28445462 pmcid: 5659341 doi: 10.1038/nature22047
Brown, R. H. & Al-Chalabi, A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 162–172 (2017).
pubmed: 28700839 doi: 10.1056/NEJMra1603471
Quadrato, G., Brown, J. & Arlotta, P. The promises and challenges of human brain organoids as models of neuropsychiatric disease. Nat. Med. 22, 1220–1228 (2016).
pubmed: 27783065 doi: 10.1038/nm.4214
Velasco, S. et al. Individual brain organoids reproducibly form cell diversity of the human cerebral cortex. Nature 570, 523–527 (2019).
pubmed: 31168097 pmcid: 6906116 doi: 10.1038/s41586-019-1289-x
Cederquist, G. Y. et al. Specification of positional identity in forebrain organoids. Nat. Biotechnol. 37, 436–444 (2019).
pubmed: 30936566 pmcid: 6447454 doi: 10.1038/s41587-019-0085-3
Huch, M., Knoblich, J. A., Lutolf, M. P. & Martinez-Arias, A. The hope and the hype of organoid research. (2017) https://doi.org/10.1242/dev.150201 .
Vives, J. & Batlle-Morera, L. The challenge of developing human 3D organoids into medicines. Stem Cell Res. Ther. 11, 1–4 (2020).
doi: 10.1186/s13287-020-1586-1
Yoon, S. J. et al. Reliability of human cortical organoid generation. Nat. Methods 16, 75–78 (2019).
pubmed: 30573846 doi: 10.1038/s41592-018-0255-0
Subramanian, A. et al. Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation. Nat. Commun. 10, 1–15 (2019).
doi: 10.1038/s41467-019-13382-0
Merkle, F. T. et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature 545, 229–233 (2017).
pubmed: 28445466 pmcid: 5427175 doi: 10.1038/nature22312
López-Erauskin, J. et al. ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron 100, 816–830.e7 (2018).
pubmed: 30344044 pmcid: 6277851 doi: 10.1016/j.neuron.2018.09.044
McCampbell, A. et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J. Clin. Investig. 128, 3558–3567 (2018).
pubmed: 30010620 pmcid: 6063493 doi: 10.1172/JCI99081
Sharma, A. et al. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 7, 10465 (2016).
pubmed: 26842965 pmcid: 4742863 doi: 10.1038/ncomms10465
Mitchell, J. C. et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol. Commun. 3, 36 (2015).
pubmed: 26108367 pmcid: 4479086 doi: 10.1186/s40478-015-0212-4
Fil, D. et al. Mutant profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Hum. Mol. Genet. 26, 686–701 (2017).
pubmed: 28040732
Nguyen, K. T., Zhang, Z., Barrett, E. F. & David, G. Morphological and functional changes in innervation of a fast forelimb muscle in SOD1-G85R mice. Neurobiol. Dis. 48, 399–408 (2012).
pubmed: 22813866 pmcid: 3461106 doi: 10.1016/j.nbd.2012.07.011
Bhaduri, A. et al. Cell stress in cortical organoids impairs molecular subtype specification. Nature 578, 142–148 (2020).
pubmed: 31996853 pmcid: 7433012 doi: 10.1038/s41586-020-1962-0
Wainger, B. J. et al. Intrinsic membrane hyperexcitability of ALS patient-derived motor neurons. Cell Rep. 7, 1–11 (2014).
pubmed: 24703839 pmcid: 4023477 doi: 10.1016/j.celrep.2014.03.019
LeMasson, G., Przedborski, S. & Abbott, L. F. A computational model of motor neuron degeneration. Neuron 83, 975–988 (2014).
doi: 10.1016/j.neuron.2014.07.001
Devlin, A.-C. et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat. Commun. 6, 1–12 (2015).
Westergard, T. et al. Repeat-associated non- AUG translation in C9orf72- ALS/FTD is driven by neuronal excitation and stress. EMBO Mol. Med. 11, (2019).
Kiskinis, E. et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14, 781–795 (2014).
pubmed: 24704492 pmcid: 4653065 doi: 10.1016/j.stem.2014.03.004
Weskamp, K. et al. Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS. J. Clin. Investig. 130, 1139–1155 (2020).
pubmed: 31714900 pmcid: 7269575 doi: 10.1172/JCI130988
Boillée, S. et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389–1392 (2006).
pubmed: 16741123 doi: 10.1126/science.1123511
Ilieva, H., Polymenidou, M. & Cleveland, D. W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761–772 (2009).
pubmed: 19951898 pmcid: 2806318 doi: 10.1083/jcb.200908164
Imlach, W. L. et al. SMN is required for sensory-motor circuit function in Drosophila. Cell 151, 427–439 (2012).
pubmed: 23063130 pmcid: 3475188 doi: 10.1016/j.cell.2012.09.011
Zhou, C., Feng, Z. & Ko, C.-P. Defects in motoneuron-astrocyte interactions in spinal muscular atrophy. J. Neurosci. 36, 2543–2553 (2016).
pubmed: 26911699 pmcid: 6705489 doi: 10.1523/JNEUROSCI.3534-15.2016
Sorge, R. E. et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat. Neurosci. 18, 1081–1083 (2015).
pubmed: 26120961 pmcid: 4772157 doi: 10.1038/nn.4053
Di Giorgio, F. P., Boulting, G. L., Bobrowicz, S. & Eggan, K. C. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3, 637–648 (2008).
pubmed: 19041780 doi: 10.1016/j.stem.2008.09.017
Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481–487 (2017).
pubmed: 28099414 pmcid: 5404890 doi: 10.1038/nature21029
Park, J. et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease. Nat. Neurosci. 21, 941–951 (2018).
pubmed: 29950669 pmcid: 6800152 doi: 10.1038/s41593-018-0175-4
Blanchard, J. W. et al. Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat. Med. 26, 952–963 (2020).
pubmed: 32514169 pmcid: 7704032 doi: 10.1038/s41591-020-0886-4
Haimon, Z. et al. Re-evaluating microglia expression profiles using RiboTag and cell isolation strategies. Nat. Immunol. 19, 636–644 (2018).
pubmed: 29777220 pmcid: 5986066 doi: 10.1038/s41590-018-0110-6
Chambers, S. M. et al. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat. Biotechnol. 30, 715–720 (2012).
pubmed: 22750882 pmcid: 3516136 doi: 10.1038/nbt.2249
Wainger, B. J. et al. Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts. Nat. Neurosci. 18, 17–24 (2015).
pubmed: 25420066 doi: 10.1038/nn.3886
Blanchard, J. W. et al. Selective conversion of fibroblasts into peripheral sensory neurons. Nat. Neurosci. 18, 25–35 (2015).
pubmed: 25420069 doi: 10.1038/nn.3887
Xiao, D. et al. Generation of self-organized sensory ganglion organoids and retinal ganglion cells from fibroblasts. Sci. Adv. 6, 1V (2020).
doi: 10.1126/sciadv.aaz5858
Said, G. From nature clinical practice neurology diabetic neuropathy—a review summary and introduction. Nat. Clin. Pract. Neurol. 3, 331–340 (2007).
pubmed: 17549059 doi: 10.1038/ncpneuro0504
Rotthier, A. et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain 132, 2699–2711 (2009).
pubmed: 19651702 pmcid: 2759337 doi: 10.1093/brain/awp198
Boulting, G. L. et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29, 279–286 (2011).
pubmed: 21293464 pmcid: 3229307 doi: 10.1038/nbt.1783
Patel, A., Garcia Diaz, A., Moore, J. C., Sirabella, D. & Corneo B. Establishment and characterization of two iPSC lines derived from healthy controls. Stem Cell Res. 47, 101926 (2020).
pubmed: 32738631 doi: 10.1016/j.scr.2020.101926
Ding, Q. et al. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 12, 393–394 (2013).
pubmed: 23561441 pmcid: 3925309 doi: 10.1016/j.stem.2013.03.006
Perez-Pinera, P. et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat. Methods 10, 973–976 (2013).
pubmed: 23892895 pmcid: 3911785 doi: 10.1038/nmeth.2600
Faustino, L. et al. Regulatory T cells migrate to airways via CCR4 and attenuate the severity of airway allergic inflammation. J. Immunol. 190, 2614–2621 (2013).
pubmed: 23390295 doi: 10.4049/jimmunol.1202354
Zilionis, R. et al. Single-cell barcoding and sequencing using droplet microfluidics. Nat. Protoc. 12, 44–73 (2017).
pubmed: 27929523 doi: 10.1038/nprot.2016.154
Srivastava, A., Sarkar, H., Gupta, N. & Patro, R. RapMap: a rapid, sensitive and accurate tool for mapping RNA-seq reads to transcriptomes. Bioinformatics 32, i192–i200 (2016).
pubmed: 27307617 pmcid: 4908361 doi: 10.1093/bioinformatics/btw277
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).
pubmed: 25867923 pmcid: 4430369 doi: 10.1038/nbt.3192
Slater, C. R. The structure of human neuromuscular junctions: some unanswered molecular questions. Int. J. Mol. Sci. 18 (2017).
Custom Code. Zenodo (2021) https://doi.org/10.5281/zenodo.4893797 .

Auteurs

João D Pereira (JD)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Daniel M DuBreuil (DM)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Anna-Claire Devlin (AC)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Aaron Held (A)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Yechiam Sapir (Y)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Eugene Berezovski (E)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

James Hawrot (J)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Katherine Dorfman (K)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Vignesh Chander (V)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Brian J Wainger (BJ)

Department of Neurology, Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. brian.wainger@mgh.harvard.edu.
Department of Anesthesiology, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA. brian.wainger@mgh.harvard.edu.
Harvard Stem Cell Institute, Cambridge, MA, USA. brian.wainger@mgh.harvard.edu.
Broad Institute of Harvard University and MIT, Cambridge, MA, USA. brian.wainger@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH